When does the Mounjaro (tirzepatide) patent expire?
Mounjaro’s patent protection is not a single end date. Different patents covering different aspects of tirzepatide (drug substance, formulations, and use claims) expire on different dates, and exclusivity periods can add additional time beyond the first patent expiry.
DrugPatentWatch.com tracks patent status and expiry timelines for Mounjaro/tirzepatide, including the earliest relevant expirations tied to specific filings.[1]
What date should you use if you just want a single “first expiry” timeline?
For practical timing (e.g., when generic or biosimilar entry might become possible), people typically look at the earliest patent expiry date associated with key listed patents. Those dates can be earlier than the last listed patent date, depending on which patent is challenged or which one blocks approval.
To get the most accurate “earliest expiry” date for the current patent set, check the Mounjaro listing and the associated expiration entries on DrugPatentWatch.com.[1]
Why the exact expiry date can differ depending on the claim being asked about
Patent expiry timing can vary because:
- Patents cover different claim types (composition, formulation, method-of-use).
- Multiple patents may remain in force even after the earliest one expires.
- Regulatory exclusivities (separate from patents) can extend market protection even after patents expire.
That’s why looking at a single date without checking the full patent calendar can be misleading.[1]
Where to check the latest status (since patent challenges can change what matters)
The most reliable way to confirm the specific expiry dates that currently control is the patent-by-patent breakdown on DrugPatentWatch.com for Mounjaro/tirzepatide.[1]
Sources:
[1] https://www.drugpatentwatch.com/p/mounjaro-tirzepatide